Sg3 Management, LLC Reata Pharmaceuticals Inc Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022
BUY
$25.61 - $110.96 $230,490 - $998,640
9,000 Added 90.0%
19,000 $501,000
Q1 2021

May 17, 2021
SELL
$94.25 - $132.81 $235,625 - $332,025
-2,500 Reduced 20.0%
10,000 $997,000
Q2 2020

Aug 14, 2020
BUY
$126.3 - $176.56 $1.58 Million - $2.21 Million
12,500 New
12,500 $1.95 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email